R
Raimo K. R. Salokangas
Researcher at University of Turku
Publications - 205
Citations - 7373
Raimo K. R. Salokangas is an academic researcher from University of Turku. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 43, co-authored 180 publications receiving 6607 citations. Previous affiliations of Raimo K. R. Salokangas include Turku University Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study
Stephan Ruhrmann,Frauke Schultze-Lutter,Raimo K. R. Salokangas,Markus Heinimaa,Don H. Linszen,Peter Dingemans,Max Birchwood,Paul Patterson,Georg Juckel,Andreas Heinz,Anthony P. Morrison,Shôn Lewis,Heinrich Graf von Reventlow,Joachim Klosterkötter +13 more
TL;DR: A differential predictive clinical model of transition to first-episode psychosis is developed that identified an increased risk of psychosis with appropriate prognostic accuracy in a sample of help-seeking patients.
Journal ArticleDOI
EPA guidance on the early intervention in clinical high risk states of psychoses.
Frauke Schultze-Lutter,Chantal Michel,Stefanie Julia Schmidt,Benno Karl Edgar Schimmelmann,Nadja P. Maric,Raimo K. R. Salokangas,Anita Riecher-Rössler,M. van der Gaag,Merete Nordentoft,Andrea Raballo,Anna Meneghelli,Max Marshall,Anthony P. Morrison,Stephan Ruhrmann,Joachim Klosterkötter +14 more
TL;DR: In this article, the authors provided evidence-based recommendations on early intervention in clinical high risk (CHR) states of psychosis, assessed according to the EPA guidance on early detection, derived from a meta-analysis of current empirical evidence on the efficacy of psychological and pharmacological interventions in CHR samples.
Journal ArticleDOI
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients
Jarmo Hietala,Erkka Syvälahti,Mikko Kuoppamäki,Merja Haaparanta,Ulla Ruotsalainen,K. Vuorio,V. Räkköläinen,J. Bergman,Olof Solin,Olli Kirvelä,Raimo K. R. Salokangas +10 more
TL;DR: Alterations in striatal presynaptic dopamine function may constitute a part of disrupted neural circuits that predispose to schizophrenic psychosis.
Journal ArticleDOI
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
Jarmo Hietala,Erkka Syvälahti,Harry Vilkman,K. Vuorio,V. Räkköläinen,Jörgen Bergman,Merja Haaparanta,Olof Solin,Mikko Kuoppamäki,Esa Eronen,Ulla Ruotsalainen,Raimo K. R. Salokangas +11 more
TL;DR: The major finding in this study is that depressive symptoms in neuroleptic-naive first-admission schizophrenia are associated with low presynaptic dopamine function, which appears to be hemisphere-related and may have drug-treatment implications, e.g., in prediction of response to D2 receptor blocking antipsychotic drugs.
Journal ArticleDOI
Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or with Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis
Nikolaos Koutsouleris,Lana Kambeitz-Ilankovic,Stephan Ruhrmann,Marlene Rosen,Anne Ruef,Dominic B. Dwyer,Marco Paolini,Katharine Chisholm,Joseph Kambeitz,Theresa Haidl,André Schmidt,John E. Gillam,Frauke Schultze-Lutter,Peter Falkai,Maximilian F. Reiser,Anita Riecher-Rössler,Rachel Upthegrove,Jarmo Hietala,Raimo K. R. Salokangas,Christos Pantelis,Eva Meisenzahl,Stephen J. Wood,Stephen J. Wood,Dirk Beque,Paolo Brambilla,Stefan Borgwardt +25 more
TL;DR: Precision medicine tools could augment effective therapeutic strategies aiming at the prevention of social functioning impairments in patients with CHR states or with ROD and machine learning outperformed expert prognostication.